| |
| |
|
| Insider
Information: |
Chin Richard |
| Relationship: |
Director |
| City: |
Waltham, |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
423,413 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$147,694 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
423,413 |
|
|
| Total
Value |
$147,694 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mateon Therapeutics Inc |
MATN |
President and CEO, Dir... |
2008-01-11 |
392,074 |
2005-08-24 |
0 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Chief Executive Office... |
2021-08-27 |
0 |
2021-08-27 |
0 |
Premium* |
|
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2017-10-10 |
31,339 |
2014-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-08-27 |
4 |
D |
$9.25 |
$74,000 |
I/I |
(8,000) |
0 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-08-27 |
4 |
D |
$9.25 |
$15,810,757 |
D/D |
(1,709,271) |
0 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-08-02 |
4 |
AS |
$9.21 |
$368,240 |
D/D |
(40,000) |
1,534,271 |
0 |
% |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-07-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
320,000 |
1,574,271 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-07-02 |
4 |
AS |
$9.18 |
$367,080 |
D/D |
(40,000) |
1,894,271 |
0 |
% |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-06-16 |
4 |
AS |
$9.18 |
$367,268 |
D/D |
(40,000) |
1,934,271 |
0 |
% |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
1,980,853 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-02-01 |
4 |
D |
$5.00 |
$32,910 |
D/D |
(6,582) |
1,974,271 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-01-23 |
4 |
D |
$4.93 |
$64,894 |
D/D |
(13,163) |
1,968,353 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-01-22 |
4 |
D |
$4.93 |
$97,338 |
D/D |
(19,744) |
1,981,516 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-01-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
2,001,260 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-01-17 |
4 |
D |
$4.95 |
$104,584 |
D/D |
(21,128) |
1,963,760 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
1,984,888 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2020-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
1,951,705 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2020-02-11 |
4 |
D |
$9.22 |
$39,803 |
D/D |
(4,317) |
1,947,388 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2020-01-23 |
4 |
D |
$9.66 |
$83,511 |
D/D |
(8,645) |
1,939,205 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2020-01-22 |
4 |
D |
$9.88 |
$114,677 |
D/D |
(11,607) |
1,947,850 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2020-01-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
1,959,457 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2019-01-23 |
4 |
D |
$9.95 |
$85,984 |
D/D |
(8,646) |
1,921,957 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2019-01-22 |
4 |
D |
$10.12 |
$131,236 |
D/D |
(12,968) |
1,930,603 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2019-01-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
1,943,571 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2019-01-02 |
4 |
AS |
$10.57 |
$422,716 |
D/D |
(40,000) |
1,906,071 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2018-12-03 |
4 |
AS |
$13.28 |
$531,200 |
D/D |
(40,000) |
1,946,071 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
CEO |
• • • |
2018-11-01 |
4 |
AS |
$14.68 |
$587,200 |
D/D |
(40,000) |
1,986,071 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
President and CEO |
• • • |
2018-10-01 |
4 |
AS |
$13.28 |
$531,200 |
D/D |
(40,000) |
2,026,071 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
